02:20 AM EDT, 07/25/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

Despite negative share price action following HON's Q2 release, we viewed its second quarter results as encouraging, overall. We lift our 12-month target to $260 from $245, valuing shares at 22.6x our 2026 EPS outlook of $11.50 (up from $11.21; 2025 EPS estimate revised to $10.61 from $10.35), in line with HON's long-term historical multiple average. HON once again lifted its full-year 2025 guidance, raised to $10.45-$10.65 from $10.20-$10.50. Organic sales were a standout during the quarter, accelerating to 5% growth Y/Y as broad-based participation across HON's business segments boosted top-line performance. On the demand front, total organic orders rose 6% Y/Y to $10.5B, contributing to record backlog of $36.6B (up 10% organically) - providing visibility over the next 12 months. Overall, we continue to see upside in shares as fundamentals appear healthy and HON makes progress towards its portfolio transformation.